← Back to Search

Behavioral Intervention

Skill-Building Approach for Opioid Abuse (ISLA Trial)

N/A
Recruiting
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 year, 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a new teaching method called ISLA in 60 middle schools across six states to see if it can reduce the need for punishing students, help teachers improve their teaching methods, and improve

Who is the study for?
This trial is for educators (administrators, teachers, instructional assistants, school counselors) in middle schools who have regular contact with students. Participants will be from 60 different schools across six states and must consent to provide data through annual surveys at three time points over two years.
What is being tested?
The Inclusive Skill-building Learning Approach (ISLA) is being tested for its effectiveness in reducing exclusionary discipline practices in schools, improving teacher-student interactions, enhancing student outcomes, and decreasing substance misuse among students.
What are the potential side effects?
Since ISLA is an educational intervention rather than a medical treatment, it does not have side effects like a drug would. However, there may be unintended consequences such as increased workload or stress among educators implementing the new approach.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 year, 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 year, 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Engagement vs. Disaffection with Learning Student-report
Frequency and Duration of Use of Office Discipline Referrals, In-School Suspension, and Out-of-School Suspension
ISLA Acceptability
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Wave 2 Instructional Skill-Building Learning Approach (ISLA)Experimental Treatment1 Intervention
Delayed one year after wave 1: Following a baseline year for data collection, school staff in 15 schools will be trained and supported in implementing ISLA schoolwide for two consecutive years.
Group II: Wave 1 Instructional Skill-Building Learning Approach (ISLA)Experimental Treatment1 Intervention
Following a baseline year for data collection, school staff in 15 schools will be trained and supported in implementing ISLA schoolwide for two consecutive years.
Group III: Wave 1 Waitlist ControlActive Control1 Intervention
These 15 schools will receive no intervention while wave 1 intervention schools undergo training and coaching on ISLA.
Group IV: Wave 2 Waitlist ControlActive Control1 Intervention
These 15 schools will receive no intervention while wave 2 intervention schools undergo training and coaching on ISLA.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,582 Previous Clinical Trials
3,321,964 Total Patients Enrolled
17 Trials studying Opioid Abuse
369,364 Patients Enrolled for Opioid Abuse
University of OregonLead Sponsor
85 Previous Clinical Trials
39,162 Total Patients Enrolled
~3384 spots leftby Aug 2028